GlassScriptPhysician profile
Marianne Ebrahim
NPI 1083934129
$18,627.88
in general payments reported to CMS, 2019-2025
34 companies · $7,440 in 2025
The $7,440 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,418 · 2020: $236 · 2021: $474 · 2022: $916 · 2023: $693 · 2024: $4,451 · 2025: $7,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $2,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,400.00 |
| Food and Beverage | $2,183.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $10,400.00 | 2024-2025 | Bovine Collagen |
| Intuitive Surgical, INC. | $4,298.02 | 2019-2020 | |
| Abbvie INC. | $749.86 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $437.21 | 2023-2025 | Myfembree |
| Shield Therapeutics INC | $339.02 | 2024-2025 | |
| Astellas Pharma US INC | $329.15 | 2022-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $269.51 | 2021-2025 | |
| Exeltis, USA INC. | $268.53 | 2021-2025 | Slynd |
| Organon LLC | $217.57 | 2021-2025 | Nexplanon |
| Sage Therapeutics, LLC | $203.93 | 2022-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $182.98 | 2021-2025 | |
| Myovant Sciences INC. | $114.13 | 2022 | |
| Millicent US INC | $106.94 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Therapeuticsmd, INC. | $92.11 | 2020-2022 | |
| Agile Therapeutics, INC. | $67.03 | 2021-2023 | Twirla |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $59.44 | 2019-2024 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $58.74 | 2021-2022 | |
| Medtronic, INC. | $55.74 | 2022-2025 | Ligasure |
| Evofem Biosciences, INC. | $41.82 | 2021 | |
| Avion Pharmaceuticals | $34.86 | 2023 | Balcoltra |
| Lupin INC. | $31.86 | 2019-2021 | |
| Coopersurgical, INC. | $29.05 | 2022-2025 | Ally II Ups |
| Daiichi Sankyo INC. | $28.98 | 2022 | |
| Innovation Technologies INC | $24.59 | 2025 | Irrisept |
| Axonics, INC. | $24.16 | 2023 | Bulkamid |
| Biom'Up France Sas | $24.13 | 2021 | |
| Mylan Pharmaceuticals INC. | $19.95 | 2022 | |
| Ethicon US, LLC | $19.13 | 2021 | |
| Supernus Pharmaceuticals, INC. | $18.87 | 2025 | Qelbree |
| Pacira Pharmaceuticals Incorporated | $17.46 | 2020 | |
| Teleflex LLC | $16.42 | 2025 | Quikclot |
| Hologic Sales and Service, LLC | $15.70 | 2022 | |
| Integra Lifesciences Corporation | $15.66 | 2024 | Biofix, Biodoptix, Biodfactor |
| Becton, Dickinson and Company | $15.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marianne Ebrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.